Evidence map›Paper›PMID 38381370›Full record

ArticlePathologie (Heidelberg, Germany)2024

[Challenges of automation in quantitative evaluation of liver biopsies : Automatic quantification of liver steatosis].

Jessica Darling, Nada Abedin, Paul K Ziegler, Steffen Gretser, Barbara Walczak, Ana Paula Barreiros, Falko Schulze, Henning Reis, Peter J Wild, Nadine Flinner

Abstract readEnglish Abstract
In one paragraph

Article in Pathologie (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jessica DarlingDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland.
Nada AbedinDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland.
Paul K ZieglerDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland.
Steffen GretserDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland.
Barbara WalczakDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland.
Ana Paula BarreirosGerman Organ Procurement Organization (DSO), Frankfurt am Main, Deutschland.
Falko SchulzeDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland.
Henning ReisDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland.
Peter J WildDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland.
Nadine FlinnerDr. Senckenbergisches Institut für Pathologie, Universitätsklinikum, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Deutschland. nadine.flinner@ukffm.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), or non-alcoholic fatty liver disease (NAFLD), is a common disease that is diagnosed through manual evaluation of liver biopsies, an assessment that is subject to high interobserver variability (IBV). IBV can be reduced using automated methods.

objectivesMany existing computer-based methods do not accurately reflect what pathologists evaluate in practice. The goal is to demonstrate how these differences impact the prediction of hepatic steatosis. Additionally, IBV complicates algorithm validation. MATERIALS AND

methodsForty tissue sections were analyzed to detect steatosis, nuclei, and fibrosis. Data generated from automated image processing were used to predict steatosis grades. To investigate IBV, 18 liver biopsies were evaluated by multiple observers.

resultsArea-based approaches yielded more strongly correlated results than nucleus-based methods (⌀ Spearman rho [ρ] = 0.92 vs. 0.79). The inclusion of information regarding tissue composition reduced the average absolute error for both area- and nucleus-based predictions by 0.5% and 2.2%, respectively. Our final area-based algorithm, incorporating tissue structure information, achieved a high accuracy (80%) and strong correlation (⌀ Spearman ρ = 0.94) with manual evaluation.

conclusionThe automatic and deterministic evaluation of steatosis can be improved by integrating information about tissue composition and can serve to reduce the influence of IBV.

Indexed as

Non-alcoholic Fatty Liver DiseaseAutomationBiopsyFibrosisHumansComputer-assisted image interpretationMachine learningNon-alcoholic fatty liver diseaseObserver variationReproducibility of results

Identifiers

PMID38381370
PMCPMC10901975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.